European League Against Rheumatism (EULAR) Congress 2010
Eastman S, Manning B, Qureshi F, Cavet G, Haney D, Shen Y, Alexander C, Fleischmann R, Hesterberg LK. Assay Development for Precise Measurement of Disease Activity Serum Biomarkers. Poster # THU0065.
Shen Y, Knowlton N, Turner M, Sutton C, Smith D, Chernoff D, Hesterberg LK, Carulli J, Shadick NA, Weinblatt ME, Cavet G, Centola M. Stepwise Discovery of Disease Activity Biomarkers in Rheumatoid Arthritis. Poster # THU0066.
Knowlton N, Todd DJ, Karlson EW, Shadick NA, Weinblatt ME, Schur PH, Roubenoff R, Izmailova E, Cavet G, Centola M, Lee DM. Rheumatoid Factor Interferes With Multiplex Immunoassays in Rheumatoid Arthritis Patients. Poster # THU0067.
Cavet C, Shen Y, Abraham S, Chernoff D, Hesterberg LK, Centola M, Taylor P. A Comparison of Serum and Urine Biomarkers for Predicting Radiographic Progression in Rheumatoid Arthritis. Poster # THU0485.
Ramanujan S, Centola M, Cavet G, McInnes I. Multi-Protein Biomarker Panel Integrates Critical Pathophysiologic Mechanisms in Measurement of RA Disease Activity. Poster # FRI0034.
Bakker MF, Bijlsma JWJ, Jacobs JWG, Haney D, Shen Y, Hesterberg LK, Smith D, Centola M, Lafeber FPJG, Cavet G. Performance of Serum Biomarkers and Multivariate Biomarker-Based Test to Measure Disease Activity in Early Rheumatoid Arthritis Treated According to the CAMERA Protocol. Poster # FRI0106.
Shen Y, Dirven L, Cavet G, Centola M, Dijkmans BAK, Hesterberg LK, Kerstens PJSM, Huizinga TWJ, Allaart CF. Serum Biomarkers Predict Progressive Structural Damage in the BeSt Study. Poster # SAT0049.
Fleischmann R, Curtis JR, Hamburger M, Blumstein H, Swan K, Cavet G, Chernoff D on behalf of the InFoRM Study Group. RA Population Characteristics in InFoRM: a Longitudinal Observational Study. Poster # SAT0518.
American College of Rheumatology — 2009 Annual Scientific Meeting
Shen Y, Knowlton N, Turner M, Sutton C, Smith D, Chernoff D, Hesterberg L, Roubenoff R, Shadick NA, Weinblatt M, Cavet G, Centola M. Stepwise development of a multi-protein biomarker index of RA disease activity. Presentation 345.
Alaupovic P, Giles JT, Knowlton N, Payne A, Cavet G, Centola M, Bathon JM. The apolipoprotein complex LpAII:B:C:D:E is increased in rheumatoid arthritis and is associated with carotid atherosclerosis. Presentation 602.
Cavet G, Shen Y, Abraham S, Chernoff D, Centola M, Taylor P. Predicting radiographic progression in rheumatoid arthritis with ultrasound and biomarkers. Presentation 1464.
A faculty of UK-based rheumatologists has developed an educational Web site to provide physicians with access to highlights and interviews from scientific medical congresses. All interviews on the
Web site are independently selected and reviewed. The Web site currently highlights new data from the 2009 American College of Rheumatology (ACR) Annual Meeting.
Dr. Guy Cavet from Crescendo Bioscience™ was interviewed by Professor Andrew Cope, King’s College London School of Medicine, regarding the abstract, “Stepwise Development of a Multi-Protein Biomarker Index of RA Disease Activity”. To watch this interview and learn more about Crescendo Bioscience’s research, please click here.
American College of Rheumatology — 2008 Annual Scientific Meeting
Turner M, Knowlton N, Frank MB, et al. Development of a multivariate disease activity test in rheumatoid arthritis. Presentation 1955.